Background and aim: Lamin B1 duplication has recently been described in a rare form of autosomal dominant adult-onset leukoencephalopathy associated with autonomic dysfunction. Aim of our work was to evaluate the presence of lamin B1 gene defects, in a series of eight patients with adult-onset hereditary diffuse leukoencephalopathy.
INTRODUCTION
Hereditary leukoencephalopathies are rare disorders characterized by progressive degeneration of myelin in the brain, with variable degree of involvement in the peripheral nervous system. [1] They can be classified in primary forms, where the disorder affects predominantly the white matter, and secondary leukoencephalopathies, where a more diffuse process leads to the destruction of both axons and myelin. The most common forms include autosomal recessive (e.g., Metachromatic leukodystrophy, Krabbe disease, Canavan disease, Vanishing White Matter disorder) or X-linked patterns (e.g., Adrenoleukodystrophy, Pelizaeus-Merzbacher disease). [2] Typically, the onset is in infancy or childhood. [1] Autosomal dominant forms include Alexander disease, due to mutations in the GFAP gene, CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), the most common form of hereditary stroke disorder, and the recently described adult-onset autosomal dominant leukodystrophy (ADLD, OMIM#169500), due to duplication of the LMNB1 gene. This latter was reported in four families, two Irish-American and two Japanese kindreds, and it is characterized by a homogeneous phenotype with onset between 40-50 yr with initial autonomic dysfunctions. [3] [4] [5] A limited number of families with or without autonomic dysfunctions and autosomal dominant inheritance are present in the literature, but the involvement of the LMNB1 gene is unknown. [6] [7] [8] [9] [10] [11] [12] [13] The duplication of the LMNB1 gene probably acts through a gain of function mechanism, because increased brain expression of the LMNB1 gene and its protein have been demonstrated. [5] The pathogenic mechanisms leading to the phenotype are still unknown, and it has not been clarified if the duplication is associated with different clinical phenotypes, as happens with the PLP1 gene duplication causing a wide clinical 5 spectrum of Pelizaeus-Merzbacher disease, [14] nor if point mutations in the LMNB1 gene may mimic the phenotype of the duplication.
Aim of our work was to evaluate the presence of full LMNB1 gene deletion/duplication, as well as point mutations in the coding region, in a selected a group of eight unrelated cases with an adult-onset form of leukoencephalopathy. One of these patients had a phenotype completely overlapping ADLD.
MATERIALS AND METHODS

Clinical and neuroradiological features of ADLD patients
We collected eight unrelated Italian cases with a hereditary form of adult-onset leukoencephalopathy ( Table 1 ). All patients had in common the onset above 30 yr., the slowly progression of neurological symptoms, MRI suggestive for white matter pathology, and at least one first-degree relative affected by a similar disorder. Seven patients (28, 41, 43, 69, 89, 94, and 109) were referred to this study after a molecular test for exclusion of CADASIL (DHPLC analysis of exons 2-23 of the NOTCH3 gene), whereas patient G769 was sent by a Medical Genetics Unit in Ferrara with a diagnosis of "ADLD compatible with LMNB1 duplication".
Adult-onset Alexander disease was excluded on the basis of the neuroradiological pattern of the white matter involvement. [15, 16] Analysis of the LMNB1 duplication by quantitative real-time PCR.
Gene dosage analysis was performed in a quantitative duplex PCR assay. Amplification was performed in a total of 20 µl containing 10 µl of Taqman Universal PCR Master mix (P/N 4324018, Applied Biosystems), 1 µl of RNase P kit (20X, VIC dye, P/N 4316844), 2 µl of forward (5'-gccaaaaaacagttagcagatgaa) and reverse (5'-cgaaactccaagtcctcagtaagg) specific primers (5 pmol/µl each), and 2 µl of MGB probe (6FAM-acttaaagtagatttggagaatc- 6 MGBNFQ, 100 µM) mapping within exon 3 of the human LMNB1 gene; genomic DNA was between 50-100 ng in 3 µl. For each sample a triplicate mix was prepared and aliquoted in three different wells of a 96-well plate. The thermal cycling conditions were: 2 min at 50°C, 10 min at 95°C, followed by 40 cycles 15 min 95°C and 1 min 60°C. The PCR was performed in a 96-well clear optical reaction plate 5700 apparatus (Applied Biosystems).
The gene dosage strategy was based on the relative amplification of the target sequence (LMNB1) and the coamplified internal standard RNase P. The number of LMNB1 copies was calculated using the comparative delta Ct method described by Livak and Schmittgen. [17] Analysis of the relative peak height ratio.
We compared, in patients vs. normal subjects, the sequencing profiles of heterozygous Single Nucleotide Polymoprhism (SNP) or heterozygous Short Tandem Repeats (STRs). [5] In patients carrying a duplication a relative increase of the peak corresponding to the duplicated allele was easily identified by visual inspection. This strategy was used to define the boundary of the duplicated region.
Screening for LMNB1 point mutations
The lamin B1 gene (LMNB1, 5q23. 
RESULTS
Screening for lamin B1 duplication and point mutations
We screened eight unrelated patients with an adult-form of familial leukoencephalopathy for duplications of the LMNB1 gene. Clinical and MRI features of these subjects are summarized in table 1. Using gene dosage real-time PCR and sequencing analysis of heterozygous SNP profiles, we found a positive case, whose four generations pedigree showed a clear autosomal dominant pattern (Figure 1 , III-6; Table 1 , G769). The duplication was confirmed in a second affected member of the family (III-4).
Using the analysis of relative peak height ratio of heterozygous microsatellite markers and SNPs, we defined a duplicated segment of 140-190 kb ( Figure 2 ). This region contains the LMNB1 gene, the uncharacterized transcript AX748201, and the 3' end of the MARCH3 gene ( Figure 2 ). The precise characterization of the breakpoints was not possible, although, using published primers, we excluded that this is one of the two large duplications, whose breakpoints were already characterized (families K4233, K2685 and K50069). [5] However, this duplication is similar to that described in family K4975, of Japanese origin, whose boundaries were approximate (duplication >150 kb). [5] No point mutation was found screening the coding exons and flanking introns of the LMNB1 gene in the remaining series of seven cases. At present, the patient can stand with minimal monolateral support, he is unable to walk autonomously, does not show any cranial nerve involvement, has a slightly decreased strength at both hands, moderate-severe paresis of the legs with no increase of muscular tone, areflexia at both arms and legs. Babinski sign is bilaterally present and no cerebellar signs are detectable. Urgency and incontinence are also present.
Recently, the patient underwent a new cerebral MRI. T1, T2, DP weighted images, in sagittal, axial and coronal planes, coronal T2W FLAIR images and T1W images after 10 Gadolinium injection were obtained. A diffuse T2 hyperintensity was present in the cerebellar hemispheres white matter, as well as in the posterior limbs of the internal capsulae, and the white matter of centrum semiovalis. A thin rim of periventricular white matter was spared. Corpus callosum was minimally involved. Optic radiations and U-fibers were spared (Figure 3 ).
Hypointensity of the centrum semiovalis on T1W images was present; no contrast enhancement followed Gadolinium injection (see figure 3 ). There was evidence of atrophy of corpus callosum, pons and medulla oblongata without signal anomaly, whereas ventricular volume and sulci were normal. No calcifications or cystic degeneration were detectable.
Patient III-4, clinics and neuroradiology
The The disease slowly progressed and fifteen years after the onset the patient was wheel- 
Patient II-6
We collected clinical records of patient II-6, paternal uncle of III-6, who was discharged at 61 yr. from a neurological department with a diagnosis of "pseudobulbar syndrome". His clinical history was unremarkable until 51 yr., when he developed urinary retention and incontinence, and underwent an urological surgery without any improvement.
Five years later, a difficulty in walking appeared as an increased weakness of the legs and motor impairment.
Later, he showed dysarthria and dysphagia. No deficits in cognitive function, nor psychiatric symptoms were reported from clinicians. An EMG was normal, whereas a CT scan revealed a diffuse hypodensity of periventricular and subcortical white matter, interpreted as of ischemic origin. His general conditions progressively worsened, at 68 yr.
the patient was confined to bed, and died three years later (71 yr.). DNA was not available for molecular confirmation of the LMNB1 gene duplication testing.
Clinical and neuroradiological phenotype of the LMNB1 negative patients 12 Five out of seven probands (see table 1 ) had a pedigree compatible with an autosomal dominant inheritance (the father or the mother was affected). In two families (patients 89 and 94) one brother was affected, and the clinical/MRI status of the parents was unknown.
Five probands showed a diffuse damage of the white matter, whereas two had multifocal confluent lesions. The cerebellum was involved in four. One patient complained impotence; orthostatic hypotension was the onset symptom of another patient. In four cases a psychiatric disorder co-existed: in two cases bipolar disorder was present, major 
Expression analysis of LMNB1 in a duplicated patient
We analysed levels of LMNB1 expression in lymphoblastoid cell lines of one duplicated patient (III-4) (Fig. 4) . In all the assays, the normal controls showed a limited variability of LMNB1 expression, whereas there was a marked increase in expression levels in subject III-4 (around 5-fold) relative to control samples. To verify that expression changes were not due to the reference gene used in the experiments, we performed the analysis with two different reference genes (TBP and GA6PDH), obtaining similar results ( Fig. 4 ).
DISCUSSION
Duplication of the LMNB1 gene has recently been associated with adult-onset autosomal dominant leukodystrophy (ADLD) in four families with different ethnic origin (Irish-American and Japanese). [5] All affected subjects display similar clinical features, with onset in the 4th -5th decade of life and initial involvement of the autonomic 13 nervous system, including bowel and bladder dysfunction, impotence, orthostatic hypotension and decreased sweating. These symptoms are followed by motor impairment due to pyramidal and cerebellar involvement. [3] [4] [5] 19 ] The MRI shows a diffuse alteration of the white matter signal both supra-and infratentorially, with involvement of the cerebellum, the corticospinal tracts, the corpus callosum, relative preservation of periventricular white matter and sparing of U-fibers without a significant atrophy. One further family with adult-onset autosomal dominant leukodystrophy mapped by linkage in 5q23 has been reported. [12, 13] As far as we know, there is no information on the LMNB1 genetic testing in this family.
In our series of eight unrelated probands with adult-onset hereditary leukoencephalopathies (six with an autosomal dominant pattern of inheritance), one LMNB1 duplicated patient was found (G769). The patient belonged to a large fourgeneration family with eight affected members. We collected clinical and neuroradiologic data from two of the three patients still alive. The onset and progression of the disease overlapped with those reported in the affected members of the families with LMNB1 duplication, although the neuroimaging findings in the youngest patient were slightly different, showing relative sparing of corpus callosum. Therefore, the LMNB1 duplication seems to be associated with a characteristic homogeneous phenotype highly suggestive for ADLD with autonomic dysfunction.
The duplication spans 140-190 kb, and contains the full length (and likely functional) LMNB1 gene, the AX748201 transcript of unknown significance, and the 3' portion of MARCH3. Thus, LMNB1 is the only functional gene within the duplicated segment. The duplication breakpoints are different from the two characterized so far at the nucleotide level, [5] suggesting that duplications of LMNB1 originated from independent mutational events. 14 We have also shown that LMNB1 expression levels are increased in lymphoblasts from one patient with the duplication (5 fold higher in our sample), as already observed by Padiath et al. (2006) . This suggests a complex regulation of the lamin B1 expression, not only dependent upon gene copy number.
The expression analysis of LMNB1 in lymphoblast cell lines may reveal useful to search for LMNB1 dosage increase in other forms of leukodystrophies, that could be due to mutations in this gene different from duplications.
Because a whole spectrum of genetic defects, including point mutations and genomic duplications/deletions, have been identified in the PLP1 gene associated with the X-linked form of Pelizaeus-Merzbacher disease, [14] we sequenced the entire LMNB1 gene in the seven probands lacking LMNB1 duplication. Although we did not find any mutation, this finding cannot rule out the possibility that point mutations in the LMNB1 gene cause ADLD.
The study of larger series of patients is needed to clarify this point, and to verify whether the ADLD phenotype with dysautonomic symptoms is invariably associated with the LMNB1 duplication.
The only other forms of autosomal dominant leukodystrophy/leukoencephalopathy, whose genetic basis is known, are CADASIL and Alexander disease, which were excluded in the seven non-duplicated patients because of the MR characteristics, and, for CADASIL, also the absence of mutations in the NOTCH3 gene. [16, 20, 
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